Skip to main content
Premium Trial:

Request an Annual Quote

Percorso Inks Commercialization Deal with Generation Biotech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Percorso Life Sciences announced an agreement today to commercialize Generation Biotech's SNPSeq products and help develop its business.

Generation Biotech, based in Lawrenceville, NJ., develops tools for DNA analysis. According to a statement, its proprietary bead-based haplotype- and region-specific extraction technology allows for the sequence-specific isolation of DNA segments.

Terms of the deal were not disclosed.

Perscorso is a life science marketing and consulting firm based in Plymouth Meeting, Penn.